Ferumoxytol (RiensoT) launched in the UK for treatment of iron deficiency anaemia in adults with CKD

Source: Takeda press release Area: News Takeda has announced the UK launch of ferumoxytol (RiensoT) for the treatment of iron deficiency anaemia in adults with chronic kidney disease (CKD).   The licensed dose is one or two doses of 510mg, depending on body weight and haemoglobin (Hb), given by fast intravenous injection.   Rienso is available as a 30mg/ml solution for injection (30 mg of iron as ferumoxytol). Each 17 ml vial contains 510 mg of iron as ferumoxytol. The NHS  price for 1 x 17ml vial is £65 and £390 for 6 x 17 ml vial packs.
Source: NeLM - News - Category: Drugs & Pharmacology Source Type: news